Lmr Partners LLP Prometheus Biosciences, Inc. Transaction History

Lmr Partners LLP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$22.28 - $39.54 $1.11 Million - $1.98 Million	-50,000 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$20.89 - $26.96 $940,990 - $1.21 Million	-45,045 Reduced 47.39%	50,000 $1.19 Million
Q2 2021 Aug 16, 2021	SELL	$16.8 - $29.65 $66,444 - $117,265	-3,955 Reduced 3.99%	95,045 $2.33 Million
Q1 2021 May 17, 2021	BUY	$16.51 - $25.29 $1.63 Million - $2.5 Million	99,000 New	99,000 $1.81 Million

29.6K

Ticker RXDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,904,100
Description
Prometheus Biosciences, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of novel therapeutics and companion diagnostics products for the treatment of inflammatory bowel diseases (IBD). Its lead product includes PRA023, a humanized IgG1 monoclonal antibody (mAb), which is in Phase IIa clinical trial...

Get notified when there are updates to the investment portfolio of Lmr Partners LLP, based on Form 13F filings with the SEC.

Stay updated on Lmr Partners LLP with notifications on news.